Abstract
Extracellular vesicles (EVs) are important mediators of communication between tumor cells and normal cells. These vesicles are rich in a variety of contents such as RNA, DNA, and proteins, and can be involved in angiogenesis, epithelial-mesenchymal transition, the formation of pre-metastatic ecological niches, and the regulation of the tumor microenvironment. Small extracellular vesicles (sEVs) are a type of EVs. Currently, the main treatments for urological tumors are surgery, radiotherapy, and targeted therapy. However, urological tumors are difficult to diagnose and treat due to their high metastatic rate, tendency to develop drug resistance, and the low sensitivity of liquid biopsies. Numerous studies have shown that sEVs offer novel therapeutic options for tumor treatment, such as tumor vaccines and tumor drug carriers. sEVs have attracted a great deal of attention owing to their contribution to in intercellular communication, and as novel biomarkers, and role in the treatment of urological tumors. This article reviews the research and applications of sEVs in the diagnosis and treatment of urological tumors.
Funder
Natural Science Foundation of Jiangxi Province
Health Commission of Jiangxi Province
Reference130 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019
2. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease study 2019;Safiri;BMJ Glob. Health,2021
3. Treatment of Advanced Prostate Cancer;Teo;Annu. Rev. Med.,2019
4. Renal Cell Carcinoma: Diagnosis and Management;Gray;Am. Fam. Phys.,2019
5. Zebrowska, A., Widlak, P., Whiteside, T., and Pietrowska, M. (2020). Signaling of Tumor-Derived sEV Impacts Melanoma Progression. Int. J. Mol. Sci., 21.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献